<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02440932</url>
  </required_header>
  <id_info>
    <org_study_id>200130139</org_study_id>
    <nct_id>NCT02440932</nct_id>
  </id_info>
  <brief_title>Impact of Phenylketonuria-type Diet on Appetite, Appetite Hormones and Diet Induced Thermogenesis</brief_title>
  <official_title>Impact of Phenylketonuria-type Diet on Appetite, Appetite Hormones and Diet Induced Thermogenesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Glasgow</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Glasgow</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low-phenylalanine diets are commonly prescribed to people with phenylketonuria (PKU), an
      inborn disease which causes accumulation of amino acid phenylalanine (Phe) in the blood. High
      blood Phe levels can cause mental, behavioural, neurological, and physical problems. Thus,
      low-phenylalanine diets help patients to manage their condition but it is not clear whether
      they have an impact on appetite, energy intake and changes in body weight. This is important
      to explore as prevalence of obesity in this population is rising high. This study aims to
      find out the effect of PKU-type meals on appetite, appetite biomarkers, and post-meal energy
      expenditure. The investigators will recruit 26 healthy adults and ask them to participate in
      two experimental trials. On one occasion the participants will be asked to consume a
      PKU-supplemented drink followed by a PKU type-lunch and on another occasion the supplement
      and lunch will be based on normally consumed foods. Series of blood samples will be taken and
      appetite will be assessed during both experiments. Both experimental trials will finish with
      consuming an &quot;all-you-can-eat&quot; buffet.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Appetite hormone: peptide YY (PYY)</measure>
    <time_frame>300 minutes</time_frame>
    <description>Plasma concentration at baseline (0 minute) and after ingestion of supplement (at 30, 60 and 90 minutes) and lunch (at 120, 150,180, 210, 240, 270 and 300 minutes)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Appetite hormone: glucagon-like peptide-1 (GLP-1)</measure>
    <time_frame>300 minutes</time_frame>
    <description>Plasma concentration at baseline (0 minute) and after ingestion of supplement (at 30, 60 and 90 minutes) and lunch (at 120, 150,180, 210, 240, 270 and 300 minutes)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Appetite hormone: cholecystokinin (CCK)</measure>
    <time_frame>300 minutes</time_frame>
    <description>Plasma concentration at baseline (0 minute) and after ingestion of supplement (at 30, 60 and 90 minutes) and lunch (at 120, 150,180, 210, 240, 270 and 300 minutes)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Appetite hormone: insulin</measure>
    <time_frame>300 minutes</time_frame>
    <description>Plasma concentration at baseline (0 minute) and after ingestion of supplement (at 30, 60 and 90 minutes) and lunch (at 120, 150,180, 210, 240, 270 and 300 minutes)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Appetite hormone: ghrelin</measure>
    <time_frame>300 minutes</time_frame>
    <description>Plasma concentration at baseline (0 minute) and after ingestion of supplement (at 30, 60 and 90 minutes) and lunch (at 120, 150,180, 210, 240, 270 and 300 minutes)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective appetite score</measure>
    <time_frame>300 minutes</time_frame>
    <description>Visual analogue scale (VAS) collected at baseline and after each blood sample collection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet induced thermogenesis</measure>
    <time_frame>300 minutes</time_frame>
    <description>Metabolic rate by means of computerised open-circuit ventilated hood system collected at baseline and after each blood sample collection for the duration of 20 minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Taste perception of PKU supplements/foods</measure>
    <time_frame>10 minutes</time_frame>
    <description>Immediately after supplement ingestion and lunch consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption time for PKU supplements/foods</measure>
    <time_frame>20 minutes</time_frame>
    <description>Maximum 5 minutes for supplement ingestion and maximum 20 minutes for lunch consumption</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Phenylketonuria (PKU)</condition>
  <arm_group>
    <arm_group_label>Phenylketonuria-type diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Breakfast: one pouch of amino acid supplement (174 mls supplemented drink PKU cooler 20, VitafloÂ®; 20 g protein, 9.4 g carbohydrates, 0.7 g Fat) Lunch: cheese sandwich [low protein bread (Juvela, UK), no protein vegan cheese (Viotros, UK)], low protein crackers (Vitaflo, UK), and low protein cookies (Juvela, UK).
Dinner: ad libitum buffet meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Breakfast: 174 ml of milk (20 g protein, 9.4 g carbohydrates, 0.7 g Fat) Lunch: cheese sandwich, crackers, and cookies (regular foods) Dinner: ad libitum buffet meal</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Phenylketonuria-type diet</intervention_name>
    <description>Breakfast, lunch and open buffet dinner</description>
    <arm_group_label>Phenylketonuria-type diet</arm_group_label>
    <arm_group_label>Normal diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal (control) diet</intervention_name>
    <description>Breakfast, lunch and open buffet dinner</description>
    <arm_group_label>Phenylketonuria-type diet</arm_group_label>
    <arm_group_label>Normal diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy adult

          2. Body weight stable for previous 4 months

          3. Regular menstrual cycle (females)

        Exclusion Criteria:

          1. Pregnancy or lactation (females)

          2. History of eating disorder

          3. History of gastrointestinal problems or surgery

          4. History of allergy

          5. History of chronic illness

          6. On any medication

          7. Smoking

          8. On nutritional supplements

          9. Following specific diet

         10. Currently taking part in other research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dalia Malkova, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Glasgow</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Human Nutrition, School of Medicine, University of Glasgow</name>
      <address>
        <city>Glasgow</city>
        <zip>G31 2ER</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2015</study_first_submitted>
  <study_first_submitted_qc>May 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2015</study_first_posted>
  <last_update_submitted>May 20, 2016</last_update_submitted>
  <last_update_submitted_qc>May 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Glasgow</investigator_affiliation>
    <investigator_full_name>Dr Dalia Malkova</investigator_full_name>
    <investigator_title>Senior Lecturer</investigator_title>
  </responsible_party>
  <keyword>low Phenylalanine diet</keyword>
  <keyword>PKU supplements</keyword>
  <keyword>diet induced thermogenesis</keyword>
  <keyword>appetite</keyword>
  <keyword>body weight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylketonurias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

